Comment on “A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson’s Disease”
Main Authors: | Yi-bo He, Yong-lin Liu, Yi-min Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2017/7623954 |
Similar Items
-
A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson’s Disease
by: Liang Song, et al.
Published: (2017-01-01) -
Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review
by: Linlin Pan, et al.
Published: (2020-05-01) -
Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in <i>C. elegans</i> Model of Parkinson’s Disease
by: Pawanrat Chalorak, et al.
Published: (2021-08-01) -
Kinetic study for the optimization of ginsenoside Rg3 production by heat treatment of ginsenoside Rb1
by: Hoang Tung Vo, et al.
Published: (2015-10-01) -
Anti-Angiogenic Properties of Ginsenoside Rg3
by: Maryam Nakhjavani, et al.
Published: (2020-10-01)